People: Codexis Inc (CDXS.OQ)
20 Sep 2019
Mr. Bernard J. Kelley serves as an Independent Chairman of the Board of the Board of the Company effective November 29, 2016. He was Independent Director of Codexis, Inc., since April 2004. From 1993 to 2002, Prior to joining the Codexis Board, Mr. Kelley was President of the Merck Manufacturing Division where he was responsible for chemical, pharmaceutical and biological manufacturing and directed the activities of corporate engineering and global procurement. He also served as a member of the Merck Management Committee through his retirement in 2003. Mr. Kelley previously served as a Director of MAP Pharmaceuticals, Inc., a biotechnology company focused on developing inhalation-based therapies, as well as a Director of Aegis Analytical Corporation, an enterprise software company. He holds a B.S. in engineering from the U.S. Naval Academy.
|Total Annual Compensation, USD||120,000|
|Restricted Stock Award, USD||84,995|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||--|
|Fiscal Year Total, USD||204,995|